How toxic protein spreads in Alzheimer's disease

by Lund UniversityDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Toxic versions of the protein tau are believed to cause death of neurons of the br

Updated on: April 18,2024

How toxic protein spreads in Alzheimer's disease

by Lund UniversityDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Toxic versions of the protein tau are believed to cause death of neurons of the br

Updated on:April 18,2024

Targeting the LANDO pathway holds a potential clue to treating Alzheimer's disease

by St. Jude Children's Research HospitalBradlee Heckmann, Ph.D., of St. Jude Immunology. Credit: St. Jude Children's Research HospitalScientists at St. Jude Children's Research Hospit

Updated on: April 25,2024

Targeting the LANDO pathway holds a potential clue to treating Alzheimer's disease

by St. Jude Children's Research HospitalBradlee Heckmann, Ph.D., of St. Jude Immunology. Credit: St. Jude Children's Research HospitalScientists at St. Jude Children's Research Hospit

Updated on:April 25,2024

Adult-born dentate granule cells support the activity of hippocampal cell populations

by Ingrid Fadelli , Medical XpressConfocal image of the dentate gyrus (cyan), with labelled adult-born dentate granule cells (magenta). Image credit: Katja Hartwich/Stephen McHugh/David DupretThe dent

Updated on: February 05,2024

Adult-born dentate granule cells support the activity of hippocampal cell populations

by Ingrid Fadelli , Medical XpressConfocal image of the dentate gyrus (cyan), with labelled adult-born dentate granule cells (magenta). Image credit: Katja Hartwich/Stephen McHugh/David DupretThe dent

Updated on:February 05,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024

Assessment of balance deficits in neurocognitive disorders

by University of TsukubaCredit: Marta Wave from PexelsBalance is important to maintain in many aspects of life, but the most important may be your body's sense of balance—also known as vestib

Updated on: March 19,2024

Assessment of balance deficits in neurocognitive disorders

by University of TsukubaCredit: Marta Wave from PexelsBalance is important to maintain in many aspects of life, but the most important may be your body's sense of balance—also known as vestib

Updated on:March 19,2024

Advanced fMRI techniques reveal the brain's dynamic architecture

byMiguel Hernandez University of ElcheHierarchical distribution of connections represented in colors on the surface of a human brain. Credit: Varga, L. et al. inCell Systems(2024)Res

Updated on: September 23,2024

Advanced fMRI techniques reveal the brain's dynamic architecture

byMiguel Hernandez University of ElcheHierarchical distribution of connections represented in colors on the surface of a human brain. Credit: Varga, L. et al. inCell Systems(2024)Res

Updated on:September 23,2024

Survey shows lack of brain health awareness among women

by Cleveland ClinicCredit: Cleveland ClinicNearly two-thirds of Americans with Alzheimer's disease are women, but according to a Women's Alzheimer's Movement at Cleveland Clinic surve

Updated on: May 22,2024

Survey shows lack of brain health awareness among women

by Cleveland ClinicCredit: Cleveland ClinicNearly two-thirds of Americans with Alzheimer's disease are women, but according to a Women's Alzheimer's Movement at Cleveland Clinic surve

Updated on:May 22,2024

Negative wealth shock linked to accelerated cognitive decline

by Elana GotkineFor older adults, negative wealth shock is associated with accelerated cognitive decline and increased risks for dementia, according to a study published online Dec. 26 inJAMA Ne

Updated on: February 24,2024

Negative wealth shock linked to accelerated cognitive decline

by Elana GotkineFor older adults, negative wealth shock is associated with accelerated cognitive decline and increased risks for dementia, according to a study published online Dec. 26 inJAMA Ne

Updated on:February 24,2024

The biggest financial, legal and functional challenges of caregivers of persons living with dementia

by Ann Kellett,Texas A&M UniversityCredit: Pixabay/CC0 Public DomainAnew studypublished inJMIR Agingidentifies the major challenges and needs of the 11 million Americ

Updated on: March 02,2024

The biggest financial, legal and functional challenges of caregivers of persons living with dementia

by Ann Kellett,Texas A&M UniversityCredit: Pixabay/CC0 Public DomainAnew studypublished inJMIR Agingidentifies the major challenges and needs of the 11 million Americ

Updated on:March 02,2024

Research reveals how sleep disruption can exacerbate pain

byMassachusetts General HospitalCSD induces hyperalgesia.aExperimental diagram of the sleep deprivation experiment and behavioral testing.bSample EEG recording using wire

Updated on: January 12,2024

Research reveals how sleep disruption can exacerbate pain

byMassachusetts General HospitalCSD induces hyperalgesia.aExperimental diagram of the sleep deprivation experiment and behavioral testing.bSample EEG recording using wire

Updated on:January 12,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on: April 02,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on:April 02,2024

Dementia rates more than 20% higher among black adults than UK average

by University College LondonCrude dementia prevalence (95% CI) in those aged 65 and over, by ethnic group. Credit:Alzheimer's & Dementia(2022). DOI: 10.1002/alz.12774Dementia

Updated on: June 07,2024

Dementia rates more than 20% higher among black adults than UK average

by University College LondonCrude dementia prevalence (95% CI) in those aged 65 and over, by ethnic group. Credit:Alzheimer's & Dementia(2022). DOI: 10.1002/alz.12774Dementia

Updated on:June 07,2024